Records containing: Myasthaenia Gravis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-24A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Descartes-08 in Patients With Generalized Myasthenia Gravis (MG)
-
CLINICAL_TRIALS study record update · 2026-02-11A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
-
CLINICAL_TRIALS study record update · 2025-07-31A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
-
CLINICAL_TRIALS study record update · 2025-07-29Efgartigimod in IVIG Dependent Myasthenia Gravis Patients
-
CLINICAL_TRIALS study record update · 2025-07-18The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-02-18Neuromuscular Complications of MEK Inhibitors: a French Case Series and a Systematic Review of the Literature
-
CLINICAL_TRIALS study record update · 2024-11-27Characteristics and Prognostic Outcomes of Diaphragmatic Ultrasound in Myasthenia Gravis
-
CLINICAL_TRIALS study record update · 2024-11-12Safety and Efficacy of Blinatumomab in Refractory Myasthenia Gravis
-
CLINICAL_TRIALS study record update · 2024-09-27Myasthenia Gravis Foundation of America Global MG Patient Registry
-
CLINICAL_TRIALS study record update · 2016-04-27A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)